Enterprise Value
0.00
Cash
123.6M
Avg Qtr Burn
N/A
Short % of Float
0.92%
Insider Ownership
9.29%
Institutional Own.
46.76%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
HMI-102 Details Phenylketonuria | Phase 2 Update | |
HMI-203 Details Mucopolysaccharidosis type II, Rare genetic disease, Rare diseases, Genetic disorder, Hunter syndrome MPS II | Phase 1/2 Update | |
HMI-103 Details Phenylketonuria | Failed Discontinued |